In conclusion, novel kidney injury biomarkers such as IL-6, IL-8, TNF-α, MMP-9 and NGAL are reliable AKI indicators, which enable early postoperative identification of patients who suffer from CSA-AKI. This evidence concerns the gene LCN2 and acute kidney injury.